• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入探讨过氧化物酶在癌症中的作用。

New insights into the roles of peroxiredoxins in cancer.

机构信息

First Department of Oncology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning, China.

Department of Emergency, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning, China.

出版信息

Biomed Pharmacother. 2023 Aug;164:114896. doi: 10.1016/j.biopha.2023.114896. Epub 2023 May 19.

DOI:10.1016/j.biopha.2023.114896
PMID:37210897
Abstract

Oxidative stress is one of the hallmarks of cancer. Tumorigenesis and progression are accompanied by elevated reactive oxygen species (ROS) levels and adaptive elevation of antioxidant expression levels. Peroxiredoxins (PRDXs) are among the most important antioxidants and are widely distributed in a variety of cancers. PRDXs are involved in the regulation of a variety of tumor cell phenotypes, such as invasion, migration, epithelial-mesenchymal transition (EMT) and stemness. PRDXs are also associated with tumor cell resistance to cell death, such as apoptosis and ferroptosis. In addition, PRDXs are involved in the transduction of hypoxic signals in the TME and in the regulation of the function of other cellular components of the TME, such as cancer-associated fibroblasts (CAFs), natural killer (NK) cells and macrophages. This implies that PRDXs are promising targets for cancer treatment. Of course, further studies are needed to realize the clinical application of targeting PRDXs. In this review, we highlight the role of PRDXs in cancer, summarizing the basic features of PRDXs, their association with tumorigenesis, their expression and function in cancer, and their relationship with cancer therapeutic resistance.

摘要

氧化应激是癌症的标志之一。肿瘤发生和进展伴随着活性氧(ROS)水平的升高和抗氧化剂表达水平的适应性升高。过氧化物酶(PRDXs)是最重要的抗氧化剂之一,广泛分布于各种癌症中。PRDXs 参与调节多种肿瘤细胞表型,如侵袭、迁移、上皮-间充质转化(EMT)和干性。PRDXs 还与肿瘤细胞对细胞死亡的抵抗有关,如细胞凋亡和铁死亡。此外,PRDXs 参与肿瘤微环境中缺氧信号的转导以及肿瘤微环境中其他细胞成分(如癌相关成纤维细胞(CAFs)、自然杀伤(NK)细胞和巨噬细胞)功能的调节。这意味着 PRDXs 是癌症治疗的有前途的靶点。当然,需要进一步的研究来实现靶向 PRDXs 的临床应用。在这篇综述中,我们强调了 PRDXs 在癌症中的作用,总结了 PRDXs 的基本特征、它们与肿瘤发生的关系、它们在癌症中的表达和功能以及它们与癌症治疗抵抗的关系。

相似文献

1
New insights into the roles of peroxiredoxins in cancer.深入探讨过氧化物酶在癌症中的作用。
Biomed Pharmacother. 2023 Aug;164:114896. doi: 10.1016/j.biopha.2023.114896. Epub 2023 May 19.
2
Functions of Peroxiredoxins and Their Roles in Autoimmune Diseases.过氧化物氧还蛋白的功能及其在自身免疫性疾病中的作用。
Antioxid Redox Signal. 2024 Feb;40(4-6):329-344. doi: 10.1089/ars.2022.0139. Epub 2023 Mar 27.
3
Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.线粒体过氧化物酶与活性氧在癌症发生发展中的相互作用。
Int J Mol Sci. 2019 Sep 7;20(18):4407. doi: 10.3390/ijms20184407.
4
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases.过氧化物酶体增殖物激活受体在癌症、神经退行性疾病和炎症性疾病中的作用。
Pharmacol Ther. 2016 Jul;163:1-23. doi: 10.1016/j.pharmthera.2016.03.018. Epub 2016 Apr 26.
5
Peroxiredoxins prevent oxidative stress during human sperm capacitation.过氧化物酶在人类精子获能过程中预防氧化应激。
Mol Hum Reprod. 2017 Feb 10;23(2):106-115. doi: 10.1093/molehr/gaw081.
6
Are peroxiredoxins tumor suppressors?过氧化物还原酶是肿瘤抑制因子吗?
Curr Opin Pharmacol. 2007 Aug;7(4):375-80. doi: 10.1016/j.coph.2007.04.007. Epub 2007 Jul 5.
7
oxidative stress alters thiol redox status of peroxiredoxin 1 and 6 and impairs rat sperm quality.氧化应激改变了过氧化物酶1和6的硫醇氧化还原状态,并损害大鼠精子质量。
Asian J Androl. 2017 Jan-Feb;19(1):73-79. doi: 10.4103/1008-682X.170863.
8
Peroxiredoxin 1 - an antioxidant enzyme in cancer.过氧化物酶体增殖物激活受体1——癌症中的一种抗氧化酶。
J Cell Mol Med. 2017 Jan;21(1):193-202. doi: 10.1111/jcmm.12955. Epub 2016 Sep 21.
9
The role of peroxiredoxins in cancer.过氧化物还原酶在癌症中的作用。
Mol Clin Oncol. 2017 Feb;6(2):139-153. doi: 10.3892/mco.2017.1129. Epub 2017 Jan 10.
10
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.二聚体过氧化物酶体增殖物激活受体在人类伯基特淋巴瘤中是可成药靶点。
Oncotarget. 2016 Jan 12;7(2):1717-31. doi: 10.18632/oncotarget.6435.

引用本文的文献

1
Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition.巨噬细胞和巨噬细胞外囊泡通过PRDX6介导的线粒体自噬抑制赋予癌症铁死亡抗性。
Redox Biol. 2025 Aug 16;86:103826. doi: 10.1016/j.redox.2025.103826.
2
Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.β-咔啉-3-羧酸乙酯靶向PRDX5/c-Jun轴以制定针对宫颈癌的新治疗策略。
Discov Oncol. 2025 Aug 7;16(1):1498. doi: 10.1007/s12672-025-03306-4.
3
Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2.
青蒿琥酯通过靶向PRDX1和PRDX2诱导弥漫性大B细胞淋巴瘤细胞发生铁死亡。
Cell Death Dis. 2025 Jul 11;16(1):513. doi: 10.1038/s41419-025-07822-7.
4
Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.联合靶向PRDX6和GSTP1作为神经母细胞瘤治疗的一种潜在分化策略。
Proc Natl Acad Sci U S A. 2025 Jun 24;122(25):e2427211122. doi: 10.1073/pnas.2427211122. Epub 2025 Jun 18.
5
Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.基于整合单细胞RNA测序和批量RNA测序队列对前列腺癌中过氧化物酶家族的生化复发预测能力及进展相关性进行表征
Cancer Med. 2025 May;14(9):e70855. doi: 10.1002/cam4.70855.
6
Myeloma mesenchymal stem cells' bioenergetics afford a novel selective therapeutic target.骨髓瘤间充质干细胞的生物能量学提供了一个新的选择性治疗靶点。
Oncogenesis. 2025 Apr 11;14(1):9. doi: 10.1038/s41389-025-00554-5.
7
Versatile Nanomaterials That Interfere with Ferroptosis in the Tumor Microenvironment.可干预肿瘤微环境中铁死亡的多功能纳米材料
Int J Nanomedicine. 2025 Feb 25;20:2461-2473. doi: 10.2147/IJN.S508767. eCollection 2025.
8
Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression.外周血蛋白质组生物标志物可区分癌症进展的免疫抑制特征。
Mol Oncol. 2025 Aug;19(8):2233-2248. doi: 10.1002/1878-0261.13817. Epub 2025 Feb 12.
9
PRDX6 Prevents NNMT Ubiquitination and Degradation as a Nonenzymatic Mechanism to Promote Ovarian Cancer Progression.PRDX6通过一种非酶促机制防止NNMT泛素化和降解,从而促进卵巢癌进展。
Adv Sci (Weinh). 2025 Mar;12(12):e2416484. doi: 10.1002/advs.202416484. Epub 2025 Jan 30.
10
A Pilot Study of Exosome Proteomic Profiling Reveals Dysregulated Metabolic Pathways in Endometrial Cancer.一项关于外泌体蛋白质组学分析的初步研究揭示了子宫内膜癌中代谢途径的失调。
Biomedicines. 2025 Jan 3;13(1):95. doi: 10.3390/biomedicines13010095.